NawtyBits
------
Experts said avian influenza virus may be further variation, Guangdong still - there may be sporadic cases (Xinhua / Feng Chen correspondent / Guangdong-letter) held yesterday in Shenzhen in 2008 the province disease control and prevention work meeting, the Guangdong expert assessment, avian influenza virus may be further variation, a small gathering of people of the risk of transmission. Despite the high incidence of respiratory disease in winter and spring will soon be over, Guangdong there are no signs of large-scale outbreaks, but there are still sporadic human cases of avian influenza distributed the possibility of the need to further strengthen monitoring.
Recently, the first person in China with the H5N1 avian influenza vaccine, "I hope Seoul to happiness"药监局approval by the national production. It has been revealed that the vaccine-and by the Beijing Branch of China CDC jointly developed, Ⅱ clinical study results indicated that the human body is very good immunogenicity and safety. Its application in the 18-60 age group, full immunization for the two-pin, price will not be higher than the current seasonal influenza vaccine. Many citizens are concerned about: the future is not to fight against the avian flu vaccine?
Guangdong Provincial Center for Disease Control and Prevention flow HE Jian-feng, director of the Institute said, it will mean that after the United States and China had become the second person to have bird flu vaccine technology and production capacity of the country. But the vaccine is limited to national reserves, do not go on sale. This is mainly because of the avian flu epidemic has not yet pandemic, the virus over the past few years and its continued a slight variation, until once popular, experts under the strain variation can be adjusted quickly developed a special vaccine. "This is a technical and capacity reserves, the United States is currently the case, there is no vaccine market."
http://tinyurl.com/6k4jfw
------
Experts said avian influenza virus may be further variation, Guangdong still - there may be sporadic cases (Xinhua / Feng Chen correspondent / Guangdong-letter) held yesterday in Shenzhen in 2008 the province disease control and prevention work meeting, the Guangdong expert assessment, avian influenza virus may be further variation, a small gathering of people of the risk of transmission. Despite the high incidence of respiratory disease in winter and spring will soon be over, Guangdong there are no signs of large-scale outbreaks, but there are still sporadic human cases of avian influenza distributed the possibility of the need to further strengthen monitoring.
Recently, the first person in China with the H5N1 avian influenza vaccine, "I hope Seoul to happiness"药监局approval by the national production. It has been revealed that the vaccine-and by the Beijing Branch of China CDC jointly developed, Ⅱ clinical study results indicated that the human body is very good immunogenicity and safety. Its application in the 18-60 age group, full immunization for the two-pin, price will not be higher than the current seasonal influenza vaccine. Many citizens are concerned about: the future is not to fight against the avian flu vaccine?
Guangdong Provincial Center for Disease Control and Prevention flow HE Jian-feng, director of the Institute said, it will mean that after the United States and China had become the second person to have bird flu vaccine technology and production capacity of the country. But the vaccine is limited to national reserves, do not go on sale. This is mainly because of the avian flu epidemic has not yet pandemic, the virus over the past few years and its continued a slight variation, until once popular, experts under the strain variation can be adjusted quickly developed a special vaccine. "This is a technical and capacity reserves, the United States is currently the case, there is no vaccine market."
http://tinyurl.com/6k4jfw